Polynoma LLC
- Biotech or pharma, therapeutic R&D
Polynoma is developing its late-stage cancer vaccine, seviprotimut-L, for the adjuvant treatment of melanoma, and has other cancer vaccine assets in discovery and pre-clinical stages of development.